Radical surgery following neoadjuvant chemotherapy for patients with stage IIIB cervical cancer

Annals of Surgical Oncology

Volumn 5, Issue 6, 1998, Pages 539-543

  Minagawa, Yukihisa ^a   Kigawa, Junzo ^a   Irie, Takashi ^a   Okada, Makoto ^a   Kanamori, Yasunobu ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Cisplatin; Intraarterial infusion; Neoadjuvant chemotherapy; Radical surgery

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; PEPLEOMYCIN; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; NAUSEA; PATIENT SELECTION; PROGNOSIS; SURGICAL TECHNIQUE; UTERINE CERVIX CANCER; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0031718906     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303647     Document Type: Article

References (16)

1. Mendenhall WM, Thar TL, Bova FJ, Marcus RB Jr, Morgan LS, Million RR. Prognostic and treatment factors affecting pelvic control of stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 1984;53:2649-54.
2. FIGO. Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 1991;36(suppl):38-9.
3. Lara PC, Garcia-Puche JL, Pedraza V. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma. Cancer Chemother Pharmacol 1990;26(suppl): 36-8.
4. Sardi J, Sananes C, Giaroli A, Maya G, di Paola G. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 1990;38:486-93.
5. Benedetti-Panici P, Scambia G, Baiocchi G, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer 1991; 67:372-9.
6. Rabinovich MG, Focaccia G, Ferreyra R, Elem Y, Leone BA, Vallejo CT. Neoadjuvant chemotherapy for cervical carcinoma. Obstet Gynecol 1991;78:685-8.
7. Souhami L, Gil RA, Allan SE, Canary PC, Araujo CM, Pinto LH, Silveira TR. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIb carcinoma of the cervix. J Clin Oncol 1991;9:970-7.
8. Potish RA, Twiggs LB. On the lack of demonstrated clinical benefit of neoadjuvant cisplatinum therapy for cervical cancer. Int J Radiat Oncol Bio Phys 1993;27:975-9.
9. Eddy GI, Sr. Neoadjuvant chemotherapy before surgery in cervical cancer. J Natl Cancer Inst Monogr 1996;21:93-9.
10. Benedetti-Panici P, Maneschi F, Cutillo G, et al. Modified type IV-V radical hysterectomy with systemic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Cancer 1996; 78:2359-65.
11. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44: 265-72.
12. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva: WHO, 1979:16-21. Offset Publication No. 48.
13. Kigawa J, Minagawa Y, Itamochi H, Kanamori Y, Ishihara H, Terakawa N. Platinum concentrations in uterus and serum after internal iliac arterial infusion of platinum compounds in rabbits. Obstet Gynecol 1995;86:265-8.
14. Itamochi H, Kigawa J, Minagawa Y, Cheng X, Okada M, Terakawa N. Antitumor effects of internal iliac arterial infusion of platinum compounds in a rabbit cervical cancer model. Obstet Gynecol 1997;89:286-90.
15. Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984;2:498-504.
16. Schwartz JL, Rotmensch J, Beckett MA, et al. X-ray and cisdiamminedichloroplatinum (II) cross-resistance in human tumor cell lines. Cancer Res 1988;48:5133-5.